The scientific backdrop is sobering. According to United Nations figures cited by the authors, roughly 800 million people worldwide were aged 65 or older in 2023, and the global elderly population is projected to surpass one billion during the 2030s. In China alone, 310 million people, about 22 percent of the population, are now aged 60 or over. Aging brings a cascade of tissue decline: sarcopenia, insomnia, coronary heart disease, and other conditions that erode quality of life and burden health systems. Disrupted circadian rhythms are among the earliest signals of aging in both humans and flies, appearing as phase advances and sleep fragmentation. Yet while the brain’s circadian circuitry has been studied extensively, the role of clock genes inside skeletal muscle during aging remained largely unexplored, a gap the new study set out to fill.

Tim occupies a distinctive position in biology because it is highly conserved from flies to humans and performs two jobs at once. In Drosophila, the molecular clock runs on a feedback loop: the CLK/CYC protein complex switches on transcription of the Per and Tim genes, whose protein products accumulate in the cytoplasm, shuttle into the nucleus, and shut their own genes down again until degradation resets the cycle. Light rapidly degrades TIM, allowing the clock to track the day-night cycle. In mammals, the Tim homolog has shifted evolutionarily toward cell-cycle control and genome maintenance; when DNA damage or replication stress strikes, TIM stabilizes replication forks and, together with the protein Tipin, helps activate the S-phase checkpoint, pausing the cell cycle long enough for repair. TIM also indirectly shapes metabolism, influencing glucose handling and energy balance through the clock’s downstream gene networks. What happens to these functions in aging muscle, however, was unknown.

To answer that question, the team exploited the genetic precision available in Drosophila. Using the Gal4/UAS system, they crossed flies carrying a Tim overexpression construct or a Tim RNA interference construct with flies carrying Mhc-Gal4, a driver that acts specifically in muscle. The resulting male offspring overexpressed, underexpressed, or normally expressed Tim exclusively in their muscles. Exercise was imposed with a rotating power tower apparatus: vials spun at 60 radians per second forced flies to repeatedly climb, with structured sessions totaling roughly an hour of activity per day, following a two-days-on, one-day-off rhythm for four weeks starting at two weeks of age. The researchers then measured 24-hour locomotor activity from video, climbing speed, heart rate and stroke volume captured by high-speed video of surgically exposed beating hearts, time to cardiac arrest under artificial hemolymph, and lifespan across groups of roughly 200 flies each.

The results from genetic suppression were striking. In one-week-old young flies, knocking down muscle Tim changed nothing measurable: activity, climbing speed, heart rate, stroke volume, and hypoxic cardiac failure time all remained normal. But by five weeks of age, the RNAi flies began falling apart. Their nighttime activity rose significantly, a signature of fragmented sleep, while climbing speed dropped, heart rate climbed, stroke volume shrank, hearts failed faster under hypoxia, and lifespan shortened. Aging itself pushed normal flies in the same direction, increasing nighttime activity and stressing the heart, but the Tim knockdown made everything worse. The overexpression experiment provided the mirror image: in aged flies, extra muscle Tim significantly reduced nighttime restlessness, boosted climbing speed, lowered heart rate, improved stroke volume, extended time to hypoxic heart failure, and lengthened lifespan, with no effect whatsoever in young flies. Tim, in other words, appears to govern how muscle ages, not how it develops or functions in youth.

Zooming into the muscle itself revealed the mechanism. Quantitative PCR and biochemical assays showed that Tim knockdown suppressed the expression of Clk, Sir2, and PGC-1alpha, reduced the mitochondrial respiratory chain complex I protein MRCC-I, decreased the expression of the contractile protein gene Mhc and its protein product, and lowered the activity of the antioxidant enzyme superoxide dismutase, all while reactive oxygen species accumulated. Transmission electron microscopy confirmed the damage visually: fewer mitochondria and frayed, disorganized myofibrils. Tim overexpression produced the opposite profile, upregulating the entire pathway, raising MRCC-I and SOD activity, cutting ROS, increasing mitochondrial abundance, and restoring myofibril integrity. The authors interpret this as a Timeless/Clock pathway working in parallel with a Timeless/Sir2/PGC-1alpha axis, with Sir2, the fly equivalent of the NAD+-dependent deacetylase SIRT1, promoting mitochondrial biogenesis and antioxidant defense through PGC-1alpha, a master regulator of energy metabolism.

The Sir2 connection carries real weight in aging biology. SIRT1 and related sirtuins protect heart and skeletal muscle by deacetylating and activating PGC-1alpha, which drives expression of mitochondrial assembly factors such as NRF1 and TFAM, and by activating the FOXO pathway to induce antioxidant enzymes like SOD2 and catalase. Aging depletes sirtuin levels in mammals, and SIRT1-deficient young mouse hearts show aging-like vulnerability to ischemia-reperfusion injury. What the fly study adds is the link upstream: for the first time, muscle Tim is shown to activate the Sir2/PGC-1alpha/MRCC-I pathway, positioning the circadian protein as a trigger for the mitochondrial machinery that keeps muscle and heart cells youthful.

Then comes the exercise twist. When the researchers subjected Tim knockdown flies, normal flies, and Tim overexpression flies to the four-week climbing regimen, exercise improved outcomes across all genetic backgrounds. Trained aged flies climbed faster, showed reduced overall and nighttime activity indicating better-consolidated sleep, had slower and stronger heartbeats with improved stroke volume, resisted hypoxic heart failure longer, and lived longer. Molecularly, exercise raised mRNA levels of Tim, Clk, Sir2, PGC-1alpha, and Mhc, elevated MRCC-I protein, increased mitochondrial number while reducing mitochondrial damage, boosted SOD activity, and lowered ROS. Critically, exercise upregulated Tim even in flies whose muscles were engineered for knockdown or overexpression, which positions exercise as an upstream regulator of the muscle Timeless gene rather than a bypass around it. The exercise program, in effect, retuned the same molecular circuit the genetic experiments had identified.

These findings dovetail with a broad literature showing that regular aerobic exercise ameliorates age-related sleep disturbances, preserves muscle mass, and reduces cardiovascular disease incidence, benefits that appear conserved from humans to flies. The molecular logic is also consistent: exercise raises NAD+ levels, enhancing Sirt1/Sir2 activity, which activates PGC-1alpha and FOXO to promote mitochondrial biogenesis and antioxidant capacity in muscle and heart. The new study welds these threads together by placing Tim above the sirtuin axis and showing that exercise pulls the same lever. Still, the authors are careful about limits. The Drosophila model diverges from mammalian biology; the mechanical rotation paradigm differs from voluntary human exercise; molecular measurements were confined largely to mRNA and protein levels without direct NAD+/NADH quantification or tissue-specific rescue experiments; only male flies were studied, leaving sex differences unexplored; and the precise upstream signal by which exercise, whether mechanical, metabolic, or redox-sensitive, elevates Tim expression remains unknown.

Even with those caveats, the implications are compelling. The work reframes skeletal muscle not merely as an engine of movement but as an endocrine and circadian organ whose internal clock helps time the aging of the whole organism, including the heart. If a conserved clock gene in muscle mediates exercise’s systemic benefits, future interventions might target the Timeless/Sir2/PGC-1alpha axis directly, whether through drugs that boost NAD+-dependent sirtuin activity, molecules that stabilize TIM, or exercise prescriptions optimized to stimulate the pathway. For now, the humble fruit fly has delivered a message that resonates far beyond the vial: when aging frays the body’s rhythms and weakens its heart, moving the muscles may reset the molecular clock that keeps both running.

Subject of Research: Muscle-specific Timeless gene regulation of exercise-induced protection against circadian, muscular, and cardiac aging in Drosophila

Article Title: Muscle‐Specific Upregulation of Timeless Mediates Exercise‐Induced Amelioration of Age‐Related Circadian Rhythm Disruption and Cardiac Dysfunction in Drosophila

Article References: Wen, D.-T., Lv, S., Sun, J.-Y., Chen, Y.-Q., Lin, Y., Du, Z.-R., Sun, G.-B., Yuan, T.-S., Shu, D., & Hou, W.-Q. (2026). Muscle‐Specific Upregulation of Timeless Mediates Exercise‐Induced Amelioration of Age‐Related Circadian Rhythm Disruption and Cardiac Dysfunction in Drosophila. Aging Cell, 25(9), Article e70708. https://doi.org/10.1111/acel.70708

Image Credits: AI Generated

DOI: 10.1111/acel.70708

Keywords: Timeless gene, circadian rhythm, exercise, aging, Drosophila, skeletal muscle, cardiac dysfunction, Sir2, PGC-1alpha, mitochondria, oxidative stress, sleep fragmentation

Thrombospondin-1 has historically been studied through the lens of its anti-angiogenic activity, particularly its ability to inhibit new blood vessel formation through interactions with endothelial cell receptors. But the protein is large, structurally complex, and released into the extracellular space by many cell types, and accumulating evidence has hinted that its domains may carry out distinct, even opposing, functions. The new work focuses on the N-terminal portion, the segment at the beginning of the protein chain, and asks what happens when this region is elevated in the circulation at a time when the body is being pushed to perform.

The central experimental strategy was to deliver the N-terminal fragment of thrombospondin-1 and then challenge animals with treadmill exercise or with cold exposure, two interventions that tax energy metabolism in fundamentally different ways. Exercise demands sustained contractile work from skeletal muscle and drives adaptations such as mitochondrial expansion, enhanced oxidative fiber recruitment, and improved glucose handling. Cold exposure, by contrast, activates thermogenesis, drawing on brown and beige adipose tissue and on shivering and non-shivering muscle heat production to defend core body temperature. The researchers reasoned that if a circulating factor could enhance adaptation to both stresses, it would be a strong candidate for a systemic coordinator of metabolic flexibility.

That is broadly what the data showed. Animals receiving the N-terminal fragment displayed greater muscle function, reflected in improved performance and force-generating capacity relative to controls undergoing the same exercise regimen. Histological and molecular analyses of the treated muscle pointed toward hallmarks of beneficial remodeling: shifts in fiber type composition toward a more oxidative profile and changes in gene expression consistent with enhanced mitochondrial and metabolic capacity. In the context of cold exposure, the fragment appeared to support tissue-specific adaptation, including responses in thermogenic fat, helping the animals meet the thermal challenge more effectively.

A key conceptual takeaway is the phrase tissue-specific metabolic adaptation. Rather than acting as a blunt metabolic accelerant, the N-terminal fragment seems to be interpreted differently by different tissues, evoking a pro-performance program in skeletal muscle during exercise and a pro-thermogenic program during cold stress. This kind of context dependence is characteristic of matricellular proteins and circulating signaling factors, whose effects depend on receptor expression patterns, local extracellular matrix composition, and concurrent physiological signals such as adrenergic tone and calcium flux. The study thus adds to a growing appreciation that exercise biology is not confined to muscle; it involves an endocrine-like dialogue among muscle, liver, adipose tissue, and the vasculature.

Mechanistically, the authors connect the fragment’s effects to established metabolic signaling hubs. Exercise adaptation is widely understood to flow through energy-sensing and transcriptional control pathways, including AMP-activated protein kinase, the master regulator of cellular energy status, and the PGC-1α coactivator that drives mitochondrial biogenesis. Enhancement of these pathways would plausibly explain both the improved contractile endurance observed in exercised animals and the greater thermogenic readiness observed under cold challenge. The fragment’s extracellular origin also raises questions about which cell-surface receptors mediate its uptake and signaling, an area where thrombospondin biology offers several candidates but no single obvious answer.

The timing of the discovery is notable. In recent years, the field has identified a parade of exercise-induced circulating factors, sometimes called exerkines, that mediate the systemic benefits of physical activity, from brain-derived neurotrophic effects to hepatic metabolic shifts. Identifying an N-terminal thrombospondin-1 fragment as a positive modulator of both exercise capacity and cold tolerance expands this catalog in an unexpected direction, because thrombospondin-1 has more often been cast as a negative regulator, for example in contexts of vascular injury, fibrosis, and tumor angiogenesis suppression. The work underscores a recurring lesson in protein biology: cleaved or independently folded domains of one protein can carry physiological meanings entirely distinct from the parent molecule.

Translational implications follow naturally, though with appropriate caveats. If the N-terminal fragment can be produced, stabilized, and safely delivered, it might one day serve as a therapy for conditions defined by muscle weakness or impaired metabolic adaptation, including sarcopenia of aging, prolonged disuse, and certain metabolic diseases. The cold-exposure component of the study adds a second, less obvious application space: enhancing thermogenic capacity could theoretically support metabolic health by increasing energy expenditure, a strategy many laboratories are pursuing through different targets. At the same time, the authors’ findings are preclinical, and the gap between improved performance in animal models and a safe, effective human intervention is notoriously wide. Dosing, receptor-mediated off-target effects, and the protein’s established roles in vascular biology would all require careful evaluation.

There are also intriguing physiological questions raised but not fully resolved. Is the endogenous N-terminal fragment released in response to exercise in humans, and if so, from which tissues? Could its levels serve as a biomarker of training status or metabolic health? And how do its effects interact with well-characterized exercise signals such as lactate, myostatin inhibitors, and the growing list of myokines and hepatokines? Answering these questions will require longitudinal studies in larger animals and, ultimately, human cohorts, as well as a more precise molecular dissection of the fragment’s receptor interactions and downstream signaling.

For now, the study offers a compelling proof of concept: a defined fragment of a familiar extracellular matrix protein can act as a systemic metabolic enhancer, amplifying the body’s own adaptive responses to exercise and to cold. As the exerkine field matures, discoveries of this kind move the conversation from cataloging what exercise does to understanding how the body broadcasts those instructions across tissues, and they hint at a future where the benefits of a hard workout or a cold morning might be partially recaptured, under medical guidance, by molecules the body already knows how to make.

Subject of Research: The role of the N-terminal fragment of thrombospondin-1 in enhancing muscle function and tissue-specific metabolic adaptation during exercise and cold exposure

Article Title: N-terminal thrombospondin-1 enhances muscle function and tissue-specific metabolic adaptation in response to exercise and cold exposure

Article References: N-terminal thrombospondin-1 enhances muscle function and tissue-specific metabolic adaptation in response to exercise and cold exposure. (n.d.). https://doi.org/10.1038/s12276-026-01830-z

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01830-z

Keywords: thrombospondin-1, exercise, metabolic adaptation, skeletal muscle, cold exposure, thermogenesis, mitochondrial biogenesis, exerkines, AMPK, PGC-1alpha, brown adipose tissue, Experimental & Molecular Medicine